Amryt Pharma plc (LON:AMYT – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 143 ($1.88) and traded as low as GBX 143 ($1.88). Amryt Pharma shares last traded at GBX 143 ($1.88), with a volume of 90,726 shares traded.
Amryt Pharma Stock Performance
The stock’s 50 day moving average price is GBX 143 and its two-hundred day moving average price is GBX 143. The firm has a market capitalization of £457.11 million and a PE ratio of -4.33. The company has a current ratio of 1.80, a quick ratio of 1.14 and a debt-to-equity ratio of 66.05.
Amryt Pharma Company Profile
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Further Reading
- Five stocks we like better than Amryt Pharma
- What is a Special Dividend?
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- 3 Small Caps With Big Return Potential
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Using the MarketBeat Dividend Tax Calculator
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
